A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis Meeting Abstract
| Authors: | Sanchez, L.; Landau, H.; Rosenbaum, C.; Abrahams, A.; Chin, C.; Liotta, B.; Agudo, N.; Ramnath, S.; Hoover, E.; Rahman, H.; Ozbek, U.; Lahoud, O.; Hassoun, H.; Osman, K. |
| Abstract Title: | A phase 1/2 study to assess safety and dose of ixazomib in combination with cyclophosphamide and dexamethasone in newly diagnosed patients with light chain (AL) amyloidosis |
| Meeting Title: | 17th International Myeloma Workshop |
| Keywords: | amyloidosis; clinical trials; ixazomib |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 19 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2019 Sep 12-15 |
| Meeting Location: | Boston, MA |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | e330 |
| End Page: | e331 |
| Language: | English |
| ACCESSION: | WOS:000491229800540 |
| DOI: | 10.1016/j.clml.2019.09.543 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: SP-217 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
